Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Rare genetic mutations in genes such as Parkin, Pink1, DJ-1, α-synuclein, LRRK2 and GBA are found to be responsible for the disease in about 15% of the cases. A key unanswered question in PD pathophysiology is why would these mutations, impacting basic cellular processes such as mitochondrial function and neurotransmission, lead to selective degeneration of SNc DA neurons? We previously showed in vitro that SNc DA neurons have an extremely high rate of mitochondrial oxidative phosphorylation and ATP production, characteristics that appear to be the result of their highly complex axonal arborization. To test the hypothesis in vivo that axon arborization size is a key determinant of vulnerability, we selectively labeled SNc or VTA DA neurons using floxed YFP viral injections in DAT-cre mice and showed that SNc DA neurons have a much more arborized axon than those of the VTA. To further enhance this difference, which may represent a limiting factor in the basal vulnerability of these neurons, we selectively deleted in mice the DA D2 receptor (D2-cKO), a key negative regulator of the axonal arbour of DA neurons. In these mice, SNc DA neurons have a 2-fold larger axonal arborization, release less DA and are more vulnerable to a 6-OHDA lesion, but not to α-synuclein overexpression when compared to control SNc DA neurons. This work adds to the accumulating evidence that the axonal arborization size of SNc DA neurons plays a key role in their vulnerability in the context of PD.
In Parkinson's disease, the most vulnerable neurons are found in the ventral tier of the substantia nigra (SN), while the adjacent dopamine (DA) neurons of the ventral tegmental area (VTA) are mostly spared. Although a significant subset of adult VTA DA neurons expresses Vglut2, a vesicular glutamate transporter, and release glutamate as a second neurotransmitter in the striatum, only very few adult SN DA neurons have this capacity. Previous work has demonstrated that lesions created by neurotoxins such as MPTP and 6-hydroxydopamine (6-OHDA) can upregulate the expression of Vglut2 in surviving DA neurons.Currently, the molecular mechanisms explaining the plasticity of Vglut2 expression in DA neurons are unknown, as are the physiological consequences for DA neuron function and survival. Here we aimed to characterize the developmental expression pattern of Vglut2 in DA neurons and the role of this transporter in post-lesional plasticity in these neurons. Using an intersectional genetic lineage-mapping approach, based on Vglut2-Cre and TH-Flpo drivers, we first found that more than 98% of DA neurons expressed Vglut2 at some point in their embryonic development. Expression of this transporter was detectable in most DA neurons until E11.5 and was found to be localized in developing axons. Moderate enhancement of VGLUT2 expression in primary DA neurons caused an increase in axonal arborization length. Compatible with a developmental role, constitutive deletion of Vglut2 caused a regional defect in TH-innervation of the dorsal striatum in E18.5 embryos. Moreover, using an in vitro neurotoxin model, we demonstrate that Vglut2 expression can be upregulated in post-lesional DA neurons by 2.5-fold, arguing that the developmental expression of Vglut2 in DA neurons can be reactivated at postnatal stages and contribute to post-lesional plasticity of dopaminergic axons. In support of this hypothesis, we find fewer mesostriatial dopaminergic projections in the striatum of conditional Vglut2 KO mice 7 weeks after a neurotoxic lesion, compared to control animals. Thus, we propose here that one of the functions of Vglut2 in adult DA neurons is to promote post-lesional recovery of meso-striatal axons.
30Chemical neurotransmission in the brain typically occurs through synapses, which are structurally 31 and functionally defined as sites of close apposition between an axon terminal and a postsynaptic 32 domain. Ultrastructural examinations of axon terminals established by monoamine neurons in 33 the brain often failed to identify a similar tight pre-and postsynaptic coupling, giving rise to the 34 concept of "diffuse" or "volume" transmission. Whether this results from intrinsic properties of 35 such modulatory neurons remains undefined. Using an efficient co-culture model, we find that 36 dopaminergic neurons establish an axonal arbor that is distinctive compared to glutamatergic or 37 GABAergic neurons in both size and propensity of terminals to avoid direct contact with target 38 neurons. Furthermore, while most dopaminergic varicosities express key proteins involved in 39 exocytosis such as synaptotagmin 1, only 20% of these are synaptic. The active zone protein 40 bassoon was found to be enriched in a subset of dopaminergic terminals that are in proximity to 41 a target cell. Irrespective of their structure, a majority of dopaminergic terminals were found to 42 be active. Finally, we found that the presynaptic protein Nrxn-1 SS4and the postsynaptic protein 43 NL-1 AB , two major components involved in excitatory synapse formation, play a critical role in the 44 formation of synapses by dopamine neurons. Taken together, our findings support the idea that 45 dopamine neurons in the brain are endowed with a distinctive developmental program that leads 46 them to adopt a fundamentally different mode of connectivity, compared to glutamatergic and 47 GABAergic neurons involved in fast point-to-point signaling. 48 49 51 SIGNIFICANCE STATEMENT 52Midbrain dopamine (DA) neurons regulate circuits controlling movement, motivation, and 53 learning. The axonal connectivity of DA neurons is intriguing due to its hyperdense nature, with a 54 particularly large number of release sites, most of which not adopting a classical synaptic 55 structure. In this study, we provide new evidence highlighting the unique ability of DA neurons to 56 establish a large and heterogeneous axonal arbor with terminals that, in striking contrast with 57 glutamate and GABA neurons, actively avoid contact with the target cells. The majority of synaptic 58 and non-synaptic terminals express proteins for exocytosis and are active. Finally, our finding 59 suggests that, NL-1 A+B and Nrxn-1 SS4-, play a critical role in the formation of synapses by DA 60 neurons. 61 62 postsynaptic coupling at most release sites, giving rise to the concept of "diffuse" or "volume" 85 transmission, whereby neurotransmitter release from non-synaptic axon terminals leads to 86 activation of metabotropic receptors on target cells located at a distance, within a sphere of a 87 few tens of microns (17)(18)(19)(20)(21)(22)(23)(24). 88The molecular mechanisms determining the ability of DA neurons to establish synaptic 89 and non-synaptic terminals are presently unknown. M...
D-amphetamine maintenance therapy shows promise as a treatment for people with cocaine addiction. Preclinical studies using Long Access (LgA) cocaine self-administration procedures suggest D-amphetamine may act by preventing tolerance to cocaine's effects at the dopamine transporter (DAT). However, Intermittent Access (IntA) cocaine self-administration better reflects human patterns of use, is especially effective in promoting addiction-relevant behaviors, and instead of tolerance, produces psychomotor, incentive, and neural sensitization. We asked, therefore, how D-amphetamine maintenance during IntA influences cocaine use and cocaine's potency at the DAT. Male rats self-administered cocaine intermittently (5 min ON, 25 min OFF x10; 5-h/session) for 14 sessions, with or without concomitant D-amphetamine maintenance therapy during these 14 sessions (5 mg/kg/day via s.c. osmotic minipump). We then assessed responding for cocaine under a progressive ratio schedule, responding under extinction and cocaine-primed reinstatement of drug seeking. We also assessed the ability of cocaine to inhibit dopamine uptake in the nucleus accumbens core using fast scan cyclic voltammetry ex vivo. IntA cocaine self-administration produced psychomotor (locomotor) sensitization, strong motivation to take and seek cocaine, and it increased cocaine's potency at the DAT. D-amphetamine coadministration suppressed the psychomotor sensitization produced by IntA cocaine experience. After cessation of D-amphetamine treatment, the motivation to take and seek cocaine was also reduced, and sensitization of cocaine's actions at the DAT was reversed. Thus, treatment with D-amphetamine might reduce cocaine use by preventing sensitization-related changes in cocaine potency at the DAT, consistent with an incentive-sensitization view of addiction.
Chemical neurotransmission typically occurs through synapses. Previous ultrastructural examinations of monoamine neuron axon terminals often failed to identify a pre-and postsynaptic coupling, leading to the concept of "volume" transmission. Whether this results from intrinsic properties of these neurons remains undefined. We find that dopaminergic neurons in vitro establish a distinctive axonal arbor compared to glutamatergic or GABAergic neurons in both size and propensity of terminals to avoid direct contact with target neurons.While most dopaminergic varicosities are active and contain exocytosis proteins like synaptotagmin 1, only ~20% of these are synaptic. The active zone protein bassoon was found to be enriched in dopaminergic terminals that are in proximity to a target cell. Finally, we found that the proteins neurexin-1α SS4− and neuroligin-1 A+B play a critical role in the formation of synapses by dopamine
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.